4 months ago
HALO
AnalystsRobert WassermanRobert Wasserman's Stock Forecasts
AnalystsRobert Wasserman
Analyst Ranking
Top 22%
#1115 out of 5290 analysts
Average Return
+4.33%
Win Rate
48%56 out of 116
Risk vs Reward
Poor
Good
Robert Wasserman's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Mindwalk Holdings CorpHYFT | +213.89% | $0.36 | $1.13 | 2025-04-01 - 2026-03-31 | Buy |
Mindwalk Holdings CorpHYFT | +192.65% | $0.68 | $1.99 | 2024-08-14 - 2025-08-13 | Buy |
Molekule Group IncMKULQ | +174.00% | $5.00 | $13.70 | 2022-02-01 - 2022-06-14 | Buy |
Nephros IncNEPH | +164.02% | $1.64 | $4.33 | 2024-11-12 - 2025-11-11 | Buy |
Ligand Pharmaceuticals IncLGND | +119.54% | $92.48 | $203.03 | 2020-02-06 - 2021-02-05 | Strong Buy |
Robert Wasserman Analyst Color
Get additional color on Robert Wasserman's coverage of popular stocks
7 months ago
LGND
7 months ago
PRLB
9 months ago
LGND
2 years ago
ITGR
2 years ago
LGND
Robert Wasserman's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Integer Holdings CorpITGR | 12 | Strong Buy | $95.00 | +2.44% | Upgrades | 4 months ago |
Halozyme Therapeutics IncHALO | 11 | Strong Buy | $90.00 | +25.70% | Maintains | 4 months ago |
Ligand Pharmaceuticals IncLGND | 12 | Strong Buy | $220.00 | -6.74% | Maintains | 7 months ago |
Proto Labs IncPRLB | 7 | Strong Buy | $55.00 | -26.47% | Maintains | 7 months ago |
Intensity Therapeutics IncINTS | 7 | Buy | $37.50 | +839.85% | Maintains | 10 months ago |
Bio Techne CorpTECH | 7 | Strong Buy | $75.00 | +41.03% | Reiterates | a year ago |
Kamada LtdKMDA | 2 | Strong Buy | $15.00 | N/A | Reiterates | a year ago |
Omniab IncOABI | 9 | Strong Buy | $6.00 | N/A | Reiterates | a year ago |
Xoma Royalty CorpXOMA | 1 | Strong Buy | $35.00 | N/A | Initiates Coverage On | a year ago |
Mindwalk Holdings CorpHYFT | 6 | Buy | $3.00 | N/A | Reiterates | a year ago |
Biolife Solutions IncBLFS | 4 | Strong Buy | $30.00 | N/A | Reiterates | a year ago |
Anebulo Pharmaceuticals IncANEB | 6 | Buy | $8.00 | N/A | Reiterates | 2 years ago |
Nephros IncNEPH | 3 | Buy | $5.00 | N/A | Reiterates | 2 years ago |
Emergent Biosolutions IncEBS | 16 | Strong Buy | $12.00 | N/A | Maintains | 2 years ago |
Codexis IncCDXS | 4 | Strong Buy | $9.00 | N/A | Reiterates | 2 years ago |
Alterity Therapeutics LtdATHE | 1 | Buy | $4.00 | N/A | Reiterates | 2 years ago |
Processa Pharmaceuticals IncPCSA | 1 | Buy | $100.00 | N/A | Reiterates | 2 years ago |
Abcellera Biologics IncABCL | 2 | Strong Buy | $12.00 | N/A | Maintains | 3 years ago |
Molekule Group IncMKULQ | 4 | Buy | $7.00 | N/A | Reiterates | 3 years ago |
Fortress Biotech IncFBIO | 1 | Buy | $75.00 | N/A | Reiterates | 3 years ago |
Repligen CorpRGEN | 1 | Strong Buy | $230.00 | N/A | Initiates Coverage On | 3 years ago |
Danaher CorpDHR | 3 | Hold | N/A | N/A | Downgrades | 4 years ago |
Thermo Fisher Scientific IncTMO | 1 | Strong Buy | $580.00 | N/A | Initiates Coverage On | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.